RUNX2 and breast cancer: However, the overexpression of RUNX2 could resist the regulation of mitochondrial damage and ferroptosis-related factors by NGR1 in breast cancer cells, and the effect of NGR1 on breast cancer was enhanced after the down-regulation of RUNX2.